|
45
|
270
|
6nmyF |
A cytokine-receptor complex |
|
24
|
151
|
6ooyA |
Asymmetric htnf-alpha |
|
28
|
151
|
6op0A |
Asymmetric htnf-alpha |
|
23
|
151
|
6oozA |
Asymmetric htnf-alpha |
|
46
|
223
|
6ppgB |
Crystal structure of il17ff bound to fab fragments of mcaf5352a |
|
50
|
212
|
6ppgA |
Crystal structure of il17ff bound to fab fragments of mcaf5352a |
|
13
|
121
|
6ppgF |
Crystal structure of il17ff bound to fab fragments of mcaf5352a |
|
16
|
129
|
6svlC |
Human myeloid-derived growth factor (mydgf) in complex with neutralizing fab |
|
43
|
221
|
6svlA |
Human myeloid-derived growth factor (mydgf) in complex with neutralizing fab |
|
26
|
135
|
6svkA |
Human myeloid-derived growth factor (mydgf) |
|
48
|
210
|
6svlB |
Human myeloid-derived growth factor (mydgf) in complex with neutralizing fab |
|
23
|
158
|
6hpiA |
Nmr structure of the pro-inflammatory cytokine interleukin-36alpha |
|
0
|
25
|
6ee9X |
Cytokine-like peptide stress-response peptide-1 from manduca sexta |
|
30
|
170
|
6i50A |
Structure of eiger tnf from s. frugiperda |
|
14
|
64
|
6aezB |
Crystal structure of human ccl5 trimer |
|
13
|
64
|
6aezA |
Crystal structure of human ccl5 trimer |
|
22
|
149
|
6rmjA |
Crystal structure of human ngr-tnf |
|
36
|
116
|
6iceA |
Crystal structure of hamster mif |
|
60
|
180
|
1a7mA |
Leukaemia inhibitory factor chimera (mh35-lif), nmr, 20 structures |
|
11
|
71
|
1g2tA |
Solution structure of eotaxin-3 |
|
30
|
140
|
1ggwA |
Cdc4p from schizosaccharomyces pombe |
|
0
|
31
|
1g26A |
The solution structure of a well-folded peptide based on the 31-residue amino-terminal subdomain of human granulin a |
|
31
|
129
|
1cylA |
Aspects of receptor binding and signalling of interleukin-4 investigated by site-directed mutagenesis and nmr spectroscopy |
|
10
|
93
|
1j8iA |
Solution structure of human lymphotactin |
|
8
|
130
|
1i16A |
Structure of interleukin 16: implications for function, nmr, 20 structures |
|
31
|
133
|
1bcnA |
Three-dimensional solution structure of human interleukin-4 by multi-dimensional heteronuclear magnetic resonance spectroscopy |
|
0
|
23
|
1irrA |
Solution structure of paralytic peptide of the silkworm, bombyx mori |
|
34
|
153
|
1irpA |
Solution structure of human interleukin-1 receptor antagonist protein |
|
14
|
157
|
1j0sA |
Solution structure of the human interleukin-18 |
|
46
|
165
|
1itfA |
Interferon alpha-2a, nmr, 24 structures |
|
0
|
28
|
1i8yA |
Semi-automatic structure determination of the cg1 3-30 peptide based on aria |
|
1
|
30
|
1i8xA |
Semi-automatic structure determination of the cg1 1-30 peptide based on aria |
|
9
|
73
|
1eihA |
Solution structure of the human chemokine eotaxin-2 |
|
13
|
71
|
1ilpA |
Cxcr-1 n-terminal peptide bound to interleukin-8 |
|
23
|
113
|
1ik0A |
Solution structure of human il-13 |
|
1
|
23
|
1b1vA |
Nmr structure of psp1, plasmatocyte-spreading peptide from pseudoplusia includens |
|
10
|
77
|
1g91A |
Solution structure of myeloid progenitor inhibitory factor-1 (mpif-1) |
|
21
|
113
|
1ga3A |
Nmr structure of interleukin-13 |
|
34
|
133
|
1itiA |
The high resolution three-dimensional solution structure of human interleukin-4 determined by multi-dimensional heteronuclear magnetic resonance spectroscopy |
|
23
|
112
|
6i9jA |
Human transforming growth factor beta2 in a tetragonal crystal form |
|
15
|
98
|
6ehzA |
Nmr solution structure of murine cxcl12 gamma isoform |
|
23
|
154
|
6ncuA |
Interleukin-37 residues 53-206- dimer |
|
47
|
309
|
6h41A |
Structure of the complex of the il-5 inhibitory peptide af17121 bound to the il-5 receptor il-5ralpha |
|
0
|
18
|
6h41B |
Structure of the complex of the il-5 inhibitory peptide af17121 bound to the il-5 receptor il-5ralpha |
|
4
|
24
|
6e1lA |
Grn3ala |
|
44
|
125
|
6e3kA |
Interferon gamma signalling complex with ifngr1 and ifngr2 |
|
40
|
125
|
6e3lA |
Interferon gamma signalling complex with ifngr1 and ifngr2 |
|
9
|
64
|
6c6dA |
20mer crystal structure of cc chemokine 5 (ccl5) |
|
21
|
151
|
6fibC |
Structure of human 4-1bb ligand |
|
21
|
151
|
6fibB |
Structure of human 4-1bb ligand |
